Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America

Background Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-res...

Full description

Saved in:
Bibliographic Details
Published in:World journal of surgery Vol. 43; no. 1; pp. 214 - 220
Main Authors: Gil, Luis, de Aretxabala, Xabier, Lendoire, Javier, Duek, Fernando, Hepp, Juan, Imventarza, Oscar
Format: Journal Article
Language:English
Published: Cham Springer International Publishing 15-01-2019
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC. Methods Patients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS). Results Of 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p  < 0.001) and disease stage ( p  < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p  < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor ( p  = 0.27). RD at any site predicted DSS ( p  < 0.001), independently of all other IGC variables. Conclusions IGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
AbstractList Background Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re‐resection for IGC. Methods Patients undergoing re‐exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South‐American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor‐treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease‐specific survival (DSS). Results Of 265 patients with IGC submitted to surgery, 168 underwent a radical re‐resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p < 0.001) and disease stage (p < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non‐RD patients (19.6 months vs. 62.7 months p < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor (p = 0.27). RD at any site predicted DSS (p < 0.001), independently of all other IGC variables. Conclusions IGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
Background Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC. Methods Patients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS). Results Of 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p  < 0.001) and disease stage ( p  < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p  < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor ( p  = 0.27). RD at any site predicted DSS ( p  < 0.001), independently of all other IGC variables. Conclusions IGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
BACKGROUNDResidual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC.METHODSPatients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS).RESULTSOf 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p < 0.001) and disease stage (p < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor (p = 0.27). RD at any site predicted DSS (p < 0.001), independently of all other IGC variables.CONCLUSIONSIGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
BackgroundResidual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC.MethodsPatients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS).ResultsOf 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p < 0.001) and disease stage (p < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor (p = 0.27). RD at any site predicted DSS (p < 0.001), independently of all other IGC variables.ConclusionsIGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC. Patients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS). Of 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p < 0.001) and disease stage (p < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor (p = 0.27). RD at any site predicted DSS (p < 0.001), independently of all other IGC variables. IGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.
Author Hepp, Juan
Imventarza, Oscar
Gil, Luis
de Aretxabala, Xabier
Lendoire, Javier
Duek, Fernando
Author_xml – sequence: 1
  givenname: Luis
  surname: Gil
  fullname: Gil, Luis
  email: drluisgil@gmail.com
  organization: Liver and Transplant Division, Hospital Dr. Cosme Argerich
– sequence: 2
  givenname: Xabier
  surname: de Aretxabala
  fullname: de Aretxabala, Xabier
  organization: Department of Surgery, Clínica Alemana
– sequence: 3
  givenname: Javier
  surname: Lendoire
  fullname: Lendoire, Javier
  organization: Liver and Transplant Division, Hospital Dr. Cosme Argerich
– sequence: 4
  givenname: Fernando
  surname: Duek
  fullname: Duek, Fernando
  organization: Liver and Transplant Division, Hospital Dr. Cosme Argerich
– sequence: 5
  givenname: Juan
  surname: Hepp
  fullname: Hepp, Juan
  organization: Department of Surgery, Clínica Alemana
– sequence: 6
  givenname: Oscar
  surname: Imventarza
  fullname: Imventarza, Oscar
  organization: Liver and Transplant Division, Hospital Dr. Cosme Argerich
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30105638$$D View this record in MEDLINE/PubMed
BookMark eNqFkd9r1TAYhoNM3Nn0D_BGAt54U_3yo03r3dnR7UwGEzfxMqTJF-1omy1pOWx_vTl0KgjiVUJ4npeXvEfkYAwjEvKSwVsGoN4lAF7VBbC6kKrixcMTsmJS8IILLg7ICkQl852JQ3KU0g0AUxVUz8ihAAZlJeoVieej7RyOk-npmen7tjfOYaQbM1qM7-k27OgXTJ2bM_ChS2gS0rX3aKdEL-fJhgFpN9LrXcicxxgzt_18Qjc5E2OiPoaBXoV5-kHXA8bOmufkqTd9wheP5zH5evrxerMtLi7Pzjfri8JKzmVRtcBRgGsMYitZyQS2desdADrB8kvtFCjpWFMqq8A5VnrvfBYqx51qxTF5s-TexnA3Y5r00CWLfW9GDHPSHOqaN_mreEZf_4XehDmOud2eUqpuSrmn2ELZGFKK6PVt7AYT7zUDvR9EL4PoPIjeD6IfsvPqMXluB3S_jV8LZKBZgF3X4_3_E_W3T1cnp9AwKbPLFzdlbfyO8U_tfzf6CZ8UqLA
CitedBy_id crossref_primary_10_1186_s12893_022_01869_5
crossref_primary_10_1016_j_ejso_2024_108397
crossref_primary_10_3390_cancers12123670
crossref_primary_10_1002_cam4_2989
crossref_primary_10_2478_raon_2021_0048
crossref_primary_10_1002_ags3_12434
crossref_primary_10_1097_ot9_0000000000000003
crossref_primary_10_3389_fonc_2022_1007374
crossref_primary_10_1007_s00423_021_02165_1
crossref_primary_10_1016_S0140_6736_21_00153_7
crossref_primary_10_1007_s11605_022_05368_z
crossref_primary_10_1245_s10434_019_08074_4
crossref_primary_10_1016_j_hpb_2022_06_014
Cites_doi 10.1007/s00464-010-0914-4
10.1053/j.semdp.2012.08.010
10.1080/00365521.2017.1284895
10.1309/AJCPQT3ELN2BBCKA
10.1245/s10434-016-5197-0
10.1007/s00268-011-1134-3
10.1245/s10434-016-5637-x
10.1245/s10434-011-1850-9
10.1097/SLA.0000000000000485
10.2217/fon.14.308
10.1016/j.ciresp.2013.11.010
10.1308/003588414X14055925060073
10.21037/cco.2016.10.01
10.1097/SLA.0b013e31822238d8
10.1001/jamasurg.2016.3642
10.1016/j.jamcollsurg.2014.01.069
10.1111/hpb.12189
10.1002/jso.21681
10.1007/s11605-017-3436-8
10.1097/SLA.0000000000000728
10.1245/s10434-014-4044-4
10.1111/j.1477-2574.2011.00325.x
10.1007/s00268-009-9950-4
10.1007/s11605-007-0309-6
10.1111/j.1477-2574.2012.00498.x
10.1111/j.1477‐2574.2012.00498.x
10.1007/978-0-387-88441-7
10.1245/s10434‐011‐1850‐9
10.1007/s00268‐009‐9950‐4
10.1245/s10434‐014‐4044‐4
10.1080/13651820310000037
10.1007/s11605‐017‐3436‐8
10.1007/s11605‐007‐0309‐6
10.1007/s00464‐010‐0914‐4
10.1245/s10434‐016‐5637‐x
10.1007/s00268‐011‐1134‐3
10.1245/s10434‐016‐5197‐0
10.1111/j.1477‐2574.2011.00325.x
ContentType Journal Article
Copyright Société Internationale de Chirurgie 2018
2019 The Author(s) under exclusive licence to Société Internationale de Chirurgie
World Journal of Surgery is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Société Internationale de Chirurgie 2018
– notice: 2019 The Author(s) under exclusive licence to Société Internationale de Chirurgie
– notice: World Journal of Surgery is a copyright of Springer, (2018). All Rights Reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QO
7T5
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
P64
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00268-018-4762-z
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Immunology Abstracts
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
Biotechnology Research Abstracts
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Technology Research Database
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-2323
EndPage 220
ExternalDocumentID 10_1007_s00268_018_4762_z
30105638
WJSBF09144
Genre article
Journal Article
GeographicLocations Chile
Argentina
South America
GeographicLocations_xml – name: Argentina
– name: Chile
– name: South America
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
123
199
1N0
203
29R
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
36B
4.4
406
408
409
40D
40E
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANZL
AAPBV
AAQQT
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFJLC
AFKRA
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHVUH
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CCPQU
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N9A
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
ROL
RPX
RRX
RSV
S16
S27
S37
S3B
SAP
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK8
WXSBR
YLTOR
Z45
Z7U
Z7V
Z7X
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8U
Z8V
Z8W
Z91
Z92
ZA5
ZMTXR
ZOVNA
~EX
1OC
AACDK
AAJBT
ABAKF
ABQWH
ACZOJ
AEFQL
AFBBN
AFFPM
AGQEE
AHBTC
AIGIU
AITYG
ALIPV
ALUQN
HGLYW
MEWTI
OVD
RIG
SUPJJ
TEORI
-Y2
.55
.GJ
1SB
2.D
28-
2P1
2VQ
3O-
3V.
53G
5QI
AAEOY
AANXM
AARHV
AAYTO
AAYZH
ABULA
ACBXY
ACUDM
ADIYS
AEBTG
AEFIE
AEKMD
AFEXP
AFFNX
AFLOW
AGGDS
AJBLW
BBWZM
CAG
CGR
COF
CUY
CVF
DCZOG
ECM
EIF
EN4
GRRUI
H13
J5H
KOW
N2Q
NDZJH
NPM
O9-
R4E
RNI
RZK
S1Z
S26
S28
SCLPG
T16
X7M
ZGI
AAMNL
AAYXX
CITATION
7QO
7T5
7XB
8FD
8FK
FR3
H94
K9.
P64
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c4224-6b02e30d9aeeb41513eb8bfd00ed31b418d7074d1957c70dd15ffdf0d96d2d7b3
IEDL.DBID AEJHL
ISSN 0364-2313
IngestDate Fri Oct 25 00:05:21 EDT 2024
Thu Oct 10 22:07:58 EDT 2024
Thu Nov 21 23:32:29 EST 2024
Wed Oct 16 00:50:26 EDT 2024
Sat Aug 24 00:48:44 EDT 2024
Sat Dec 16 12:01:04 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4224-6b02e30d9aeeb41513eb8bfd00ed31b418d7074d1957c70dd15ffdf0d96d2d7b3
Notes This article was presented at the Americas Hepato‐Pancreato‐Biliary (AHPBA) 2017 Annual Meeting in March 2017, in Miami, FL.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30105638
PQID 2087789542
PQPubID 47185
PageCount 7
ParticipantIDs proquest_miscellaneous_2088292322
proquest_journals_2087789542
crossref_primary_10_1007_s00268_018_4762_z
pubmed_primary_30105638
wiley_primary_10_1007_s00268_018_4762_z_WJSBF09144
springer_journals_10_1007_s00268_018_4762_z
PublicationCentury 2000
PublicationDate 15 January 2019
PublicationDateYYYYMMDD 2019-01-15
PublicationDate_xml – month: 01
  year: 2019
  text: 15 January 2019
  day: 15
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
– name: Lupsingen
PublicationSubtitle Official Journal of the International Society of Surgery/Société Internationale de Chirurgie
PublicationTitle World journal of surgery
PublicationTitleAbbrev World J Surg
PublicationTitleAlternate World J Surg
PublicationYear 2019
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References Butte, Kingham, Gönen (CR10) 2014; 219
Pitt, Jin, Hall (CR14) 2014; 260
Goetze, Paolucci (CR4) 2010; 24
Shindoh, de Aretxabala, Aloia (CR20) 2015; 261
Gil, Lendoire, Duek (CR9) 2014; 92
Creasy, Goldman, Gonen (CR24) 2017; 21
Sternby Eilard, Lundgren, Cahlin (CR17) 2017; 52
Shibata, Uchida, Iwaki (CR26) 2009; 33
Sirohi, Mitra, Jagannath (CR27) 2015; 11
Lendoire, Gil, Duek (CR1) 2012; 14
Pawlik, Gleisner, Vigano (CR8) 2007; 11
Birnbaum, Viganò, Russolillo (CR25) 2015; 22
Butte, Gönen, Allen (CR23) 2011; 13
Engineer, Goel, Chopra (CR28) 2016; 23
Roa, Ibacache, Muñoz (CR22) 2014; 141
Tsirlis, Ausania, White (CR16) 2015; 97
Yip, Gomez, Brown (CR15) 2014; 16
Edge, Byrd, Compton (CR12) 2010
Maker, Butte, Oxenberg (CR3) 2012; 19
Fuks, Regimbeau, Le Treut (CR6) 2011; 35
Adsay, Bagci, Tajiri (CR21) 2012; 29
Butte, Waugh, Meneses (CR2) 2010; 102
Ethun, Postlewait, Le (CR19) 2017; 24
Matsuda, Matsuda, Birnbaum (CR29) 2015; 22
Ito, Ito, D’Angelica (CR7) 2011; 254
Smith, Parks, Madhavan (CR5) 2003; 5
Ethun, Postlewait, Le (CR11) 2017; 152
Arroyo, Gentile, Parada (CR13) 2016; 5
Aloia, Járufe, Javle (CR18) 2015; 17
2015; 261
2014; 92
2015; 17
2014; 219
2010
2015; 97
2017; 21
2017; 24
2015; 11
2010; 102
2012; 19
2011; 35
2011; 13
2017; 152
2012; 14
2007; 11
2011; 254
2016; 5
2009; 33
2017; 52
2010; 24
2015; 22
2014; 16
2003; 5
2014; 260
2012; 29
2014; 141
2016; 23
e_1_2_5_26_2
e_1_2_5_27_2
e_1_2_5_24_2
e_1_2_5_25_2
e_1_2_5_22_2
e_1_2_5_23_2
e_1_2_5_20_2
e_1_2_5_21_2
e_1_2_5_28_2
e_1_2_5_29_2
e_1_2_5_14_2
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_16_2
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_12_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_3_2
e_1_2_5_2_2
Matsuda T (e_1_2_5_30_2) 2015; 22
e_1_2_5_18_2
e_1_2_5_17_2
Aloia TA (e_1_2_5_19_2) 2015; 17
References_xml – year: 2010
  ident: CR12
  publication-title: AJCC cancer staging manual
  contributor:
    fullname: Compton
– volume: 24
  start-page: 2156
  issue: 9
  year: 2010
  end-page: 2164
  ident: CR4
  article-title: Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry
  publication-title: Surg Endosc
  doi: 10.1007/s00464-010-0914-4
  contributor:
    fullname: Paolucci
– volume: 29
  start-page: 127
  issue: 3
  year: 2012
  end-page: 141
  ident: CR21
  article-title: Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
  publication-title: Semin Diagn Pathol
  doi: 10.1053/j.semdp.2012.08.010
  contributor:
    fullname: Tajiri
– volume: 52
  start-page: 505
  issue: 5
  year: 2017
  end-page: 514
  ident: CR17
  article-title: Surgical treatment for gallbladder cancer—a systematic literature review
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365521.2017.1284895
  contributor:
    fullname: Cahlin
– volume: 141
  start-page: 675
  issue: 5
  year: 2014
  end-page: 682
  ident: CR22
  article-title: Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1366 cases
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCPQT3ELN2BBCKA
  contributor:
    fullname: Muñoz
– volume: 23
  start-page: 3009
  year: 2016
  end-page: 3015
  ident: CR28
  article-title: Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5197-0
  contributor:
    fullname: Chopra
– volume: 35
  start-page: 1887
  issue: 8
  year: 2011
  end-page: 1897
  ident: CR6
  article-title: Incidental gallbladder cancer by the AFC-GBC-2009 study group
  publication-title: World J Surg
  doi: 10.1007/s00268-011-1134-3
  contributor:
    fullname: Le Treut
– volume: 24
  start-page: 1343
  issue: 5
  year: 2017
  end-page: 1350
  ident: CR19
  article-title: A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5637-x
  contributor:
    fullname: Le
– volume: 19
  start-page: 409
  issue: 2
  year: 2012
  end-page: 417
  ident: CR3
  article-title: Is port site resection necessary in the surgical management of gallbladder cancer?
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-011-1850-9
  contributor:
    fullname: Oxenberg
– volume: 260
  start-page: 128
  issue: 1
  year: 2014
  end-page: 133
  ident: CR14
  article-title: Incidental gallbladder cancer at cholecystectomy
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000000485
  contributor:
    fullname: Hall
– volume: 11
  start-page: 1501
  issue: 10
  year: 2015
  end-page: 1509
  ident: CR27
  article-title: Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer
  publication-title: Future Oncol
  doi: 10.2217/fon.14.308
  contributor:
    fullname: Jagannath
– volume: 92
  start-page: 168
  issue: 3
  year: 2014
  end-page: 174
  ident: CR9
  article-title: Cirugía radical en el cáncer de vesícula incidental: valor del hallazgo de enfermedad residual en el estudio histopatológico diferido
  publication-title: Cir Esp
  doi: 10.1016/j.ciresp.2013.11.010
  contributor:
    fullname: Duek
– volume: 97
  start-page: 131
  issue: 2
  year: 2015
  end-page: 136
  ident: CR16
  article-title: Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer
  publication-title: Ann R Coll Surg Engl
  doi: 10.1308/003588414X14055925060073
  contributor:
    fullname: White
– volume: 5
  start-page: 67
  issue: 5
  year: 2016
  ident: CR13
  article-title: Gallbladder cancer: South American experience
  publication-title: Chin Clin Oncol
  doi: 10.21037/cco.2016.10.01
  contributor:
    fullname: Parada
– volume: 254
  start-page: 320
  issue: 2
  year: 2011
  end-page: 325
  ident: CR7
  article-title: Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31822238d8
  contributor:
    fullname: D’Angelica
– volume: 22
  start-page: 299
  issue: 3
  year: 2015
  end-page: 305
  ident: CR29
  article-title: Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis
  publication-title: Ann Surg Oncol
  contributor:
    fullname: Birnbaum
– volume: 152
  start-page: 143
  issue: 2
  year: 2017
  ident: CR11
  article-title: Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival
  publication-title: JAMA Surg
  doi: 10.1001/jamasurg.2016.3642
  contributor:
    fullname: Le
– volume: 219
  start-page: 416
  issue: 3
  year: 2014
  end-page: 429
  ident: CR10
  article-title: Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2014.01.069
  contributor:
    fullname: Gönen
– volume: 16
  start-page: 641
  issue: 7
  year: 2014
  end-page: 647
  ident: CR15
  article-title: Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre
  publication-title: HPB
  doi: 10.1111/hpb.12189
  contributor:
    fullname: Brown
– volume: 102
  start-page: 620
  issue: 6
  year: 2010
  end-page: 625
  ident: CR2
  article-title: Incidental gallbladder cancer: analysis of surgical findings and survival
  publication-title: J Surg Oncol
  doi: 10.1002/jso.21681
  contributor:
    fullname: Meneses
– volume: 21
  start-page: 1254
  issue: 8
  year: 2017
  end-page: 1261
  ident: CR24
  article-title: Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-017-3436-8
  contributor:
    fullname: Gonen
– volume: 5
  start-page: 159
  issue: 3
  year: 2003
  end-page: 166
  ident: CR5
  article-title: A 10-year experience in the management of gallbladder cancer
  publication-title: HPB (Oxford)
  contributor:
    fullname: Madhavan
– volume: 261
  start-page: 733
  issue: 4
  year: 2015
  end-page: 739
  ident: CR20
  article-title: Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000000728
  contributor:
    fullname: Aloia
– volume: 22
  start-page: 811
  issue: 3
  year: 2015
  end-page: 818
  ident: CR25
  article-title: Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4044-4
  contributor:
    fullname: Russolillo
– volume: 13
  start-page: 463
  issue: 7
  year: 2011
  end-page: 472
  ident: CR23
  article-title: The role of laparoscopic staging in patients with incidental gallbladder cancer
  publication-title: HPB (Oxford)
  doi: 10.1111/j.1477-2574.2011.00325.x
  contributor:
    fullname: Allen
– volume: 17
  start-page: 681
  issue: 8
  year: 2015
  end-page: 690
  ident: CR18
  publication-title: Gallbladder cancer: expert consensus statement. HPB
  contributor:
    fullname: Javle
– volume: 33
  start-page: 1035
  issue: 5
  year: 2009
  end-page: 1041
  ident: CR26
  article-title: Lymphatic invasion: an important prognostic factor for stages T1b–T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer
  publication-title: World J Surg
  doi: 10.1007/s00268-009-9950-4
  contributor:
    fullname: Iwaki
– volume: 11
  start-page: 1478
  issue: 11
  year: 2007
  end-page: 1487
  ident: CR8
  article-title: Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-007-0309-6
  contributor:
    fullname: Vigano
– volume: 14
  start-page: 548
  issue: 8
  year: 2012
  end-page: 553
  ident: CR1
  article-title: Relevance of residual disease after liver resection for incidental gallbladder cancer
  publication-title: HPB (Oxford)
  doi: 10.1111/j.1477-2574.2012.00498.x
  contributor:
    fullname: Duek
– volume: 19
  start-page: 409
  issue: 2
  year: 2012
  end-page: 417
  article-title: Is port site resection necessary in the surgical management of gallbladder cancer?
  publication-title: Ann Surg Oncol
– volume: 261
  start-page: 733
  issue: 4
  year: 2015
  end-page: 739
  article-title: Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer
  publication-title: Ann Surg
– volume: 92
  start-page: 168
  issue: 3
  year: 2014
  end-page: 174
  article-title: Cirugía radical en el cáncer de vesícula incidental: valor del hallazgo de enfermedad residual en el estudio histopatológico diferido
  publication-title: Cir Esp
– volume: 11
  start-page: 1478
  issue: 11
  year: 2007
  end-page: 1487
  article-title: Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re‐resection
  publication-title: J Gastrointest Surg
– volume: 11
  start-page: 1501
  issue: 10
  year: 2015
  end-page: 1509
  article-title: Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer
  publication-title: Future Oncol
– volume: 14
  start-page: 548
  issue: 8
  year: 2012
  end-page: 553
  article-title: Relevance of residual disease after liver resection for incidental gallbladder cancer
  publication-title: HPB (Oxford)
– volume: 102
  start-page: 620
  issue: 6
  year: 2010
  end-page: 625
  article-title: Incidental gallbladder cancer: analysis of surgical findings and survival
  publication-title: J Surg Oncol
– volume: 52
  start-page: 505
  issue: 5
  year: 2017
  end-page: 514
  article-title: Surgical treatment for gallbladder cancerߝa systematic literature review
  publication-title: Scand J Gastroenterol
– volume: 22
  start-page: 299
  issue: 3
  year: 2015
  end-page: 305
  article-title: Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta‐analysis
  publication-title: Ann Surg Oncol
– volume: 254
  start-page: 320
  issue: 2
  year: 2011
  end-page: 325
  article-title: Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment
  publication-title: Ann Surg
– volume: 260
  start-page: 128
  issue: 1
  year: 2014
  end-page: 133
  article-title: Incidental gallbladder cancer at cholecystectomy
  publication-title: Ann Surg
– volume: 97
  start-page: 131
  issue: 2
  year: 2015
  end-page: 136
  article-title: Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer
  publication-title: Ann R Coll Surg Engl
– volume: 141
  start-page: 675
  issue: 5
  year: 2014
  end-page: 682
  article-title: Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1366 cases
  publication-title: Am J Clin Pathol
– volume: 21
  start-page: 1254
  issue: 8
  year: 2017
  end-page: 1261
  article-title: Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies
  publication-title: J Gastrointest Surg
– volume: 24
  start-page: 1343
  issue: 5
  year: 2017
  end-page: 1350
  article-title: A novel pathology‐based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10‐institution study from the U.S. extrahepatic biliary malignancy consortium
  publication-title: Ann Surg Oncol
– volume: 29
  start-page: 127
  issue: 3
  year: 2012
  end-page: 141
  article-title: Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
  publication-title: Semin Diagn Pathol
– year: 2010
– volume: 17
  start-page: 681
  issue: 8
  year: 2015
  end-page: 690
  publication-title: Gallbladder cancer: expert consensus statement. HPB
– volume: 24
  start-page: 2156
  issue: 9
  year: 2010
  end-page: 2164
  article-title: Adequate extent in radical re‐resection of incidental gallbladder carcinoma: analysis of the German Registry
  publication-title: Surg Endosc
– volume: 35
  start-page: 1887
  issue: 8
  year: 2011
  end-page: 1897
  article-title: Incidental gallbladder cancer by the AFC‐GBC‐2009 study group
  publication-title: World J Surg
– volume: 16
  start-page: 641
  issue: 7
  year: 2014
  end-page: 647
  article-title: Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre
  publication-title: HPB
– volume: 5
  start-page: 67
  issue: 5
  year: 2016
  article-title: Gallbladder cancer: South American experience
  publication-title: Chin Clin Oncol
– volume: 22
  start-page: 811
  issue: 3
  year: 2015
  end-page: 818
  article-title: Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio
  publication-title: Ann Surg Oncol
– volume: 152
  start-page: 143
  issue: 2
  year: 2017
  article-title: Association of optimal time interval to re‐resection for incidental gallbladder cancer with overall survival
  publication-title: JAMA Surg
– volume: 5
  start-page: 159
  issue: 3
  year: 2003
  end-page: 166
  article-title: A 10‐year experience in the management of gallbladder cancer
  publication-title: HPB (Oxford)
– volume: 33
  start-page: 1035
  issue: 5
  year: 2009
  end-page: 1041
  article-title: Lymphatic invasion: an important prognostic factor for stages T1b–T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer
  publication-title: World J Surg
– volume: 23
  start-page: 3009
  year: 2016
  end-page: 3015
  article-title: Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm
  publication-title: Ann Surg Oncol
– volume: 13
  start-page: 463
  issue: 7
  year: 2011
  end-page: 472
  article-title: The role of laparoscopic staging in patients with incidental gallbladder cancer
  publication-title: HPB (Oxford)
– volume: 219
  start-page: 416
  issue: 3
  year: 2014
  end-page: 429
  article-title: Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer
  publication-title: J Am Coll Surg
– ident: e_1_2_5_16_2
  doi: 10.1111/hpb.12189
– volume: 17
  start-page: 681
  issue: 8
  year: 2015
  ident: e_1_2_5_19_2
  publication-title: Gallbladder cancer: expert consensus statement. HPB
  contributor:
    fullname: Aloia TA
– ident: e_1_2_5_23_2
  doi: 10.1309/AJCPQT3ELN2BBCKA
– ident: e_1_2_5_2_2
  doi: 10.1111/j.1477‐2574.2012.00498.x
– ident: e_1_2_5_13_2
  doi: 10.1007/978-0-387-88441-7
– ident: e_1_2_5_28_2
  doi: 10.2217/fon.14.308
– ident: e_1_2_5_3_2
  doi: 10.1002/jso.21681
– ident: e_1_2_5_4_2
  doi: 10.1245/s10434‐011‐1850‐9
– ident: e_1_2_5_27_2
  doi: 10.1007/s00268‐009‐9950‐4
– ident: e_1_2_5_12_2
  doi: 10.1001/jamasurg.2016.3642
– ident: e_1_2_5_26_2
  doi: 10.1245/s10434‐014‐4044‐4
– ident: e_1_2_5_22_2
  doi: 10.1053/j.semdp.2012.08.010
– volume: 22
  start-page: 299
  issue: 3
  year: 2015
  ident: e_1_2_5_30_2
  article-title: Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta‐analysis
  publication-title: Ann Surg Oncol
  contributor:
    fullname: Matsuda T
– ident: e_1_2_5_10_2
  doi: 10.1016/j.ciresp.2013.11.010
– ident: e_1_2_5_8_2
  doi: 10.1097/SLA.0b013e31822238d8
– ident: e_1_2_5_6_2
  doi: 10.1080/13651820310000037
– ident: e_1_2_5_25_2
  doi: 10.1007/s11605‐017‐3436‐8
– ident: e_1_2_5_9_2
  doi: 10.1007/s11605‐007‐0309‐6
– ident: e_1_2_5_5_2
  doi: 10.1007/s00464‐010‐0914‐4
– ident: e_1_2_5_20_2
  doi: 10.1245/s10434‐016‐5637‐x
– ident: e_1_2_5_14_2
  doi: 10.21037/cco.2016.10.01
– ident: e_1_2_5_17_2
  doi: 10.1308/003588414X14055925060073
– ident: e_1_2_5_15_2
  doi: 10.1097/SLA.0000000000000485
– ident: e_1_2_5_18_2
  doi: 10.1080/00365521.2017.1284895
– ident: e_1_2_5_21_2
  doi: 10.1097/SLA.0000000000000728
– ident: e_1_2_5_7_2
  doi: 10.1007/s00268‐011‐1134‐3
– ident: e_1_2_5_29_2
  doi: 10.1245/s10434‐016‐5197‐0
– ident: e_1_2_5_11_2
  doi: 10.1016/j.jamcollsurg.2014.01.069
– ident: e_1_2_5_24_2
  doi: 10.1111/j.1477‐2574.2011.00325.x
SSID ssj0017606
Score 2.4092543
Snippet Background Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder...
Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer...
BackgroundResidual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder...
BACKGROUNDResidual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder...
SourceID proquest
crossref
pubmed
wiley
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 214
SubjectTerms Abdominal Surgery
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Adenocarcinoma - surgery
Adult
Aged
Argentina - epidemiology
Bile ducts
Cancer
Cardiac Surgery
Chemotherapy
Chile - epidemiology
Cholecystectomy
Correlation analysis
Demographic variables
Demographics
Demography
Female
Gallbladder
Gallbladder cancer
Gallbladder Neoplasms - mortality
Gallbladder Neoplasms - pathology
Gallbladder Neoplasms - surgery
General Surgery
Humans
Incidental Findings
Laparoscopy
Lymph nodes
Male
Medical prognosis
Medicine
Medicine & Public Health
Middle Aged
Neoplasm, Residual - mortality
Neoplasm, Residual - pathology
Neoplasm, Residual - surgery
Original Scientific Report
Patients
Prognosis
Reoperation
Retrospective Studies
Surgery
Survival
Thoracic Surgery
Variables
Vascular Surgery
Title Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America
URI https://link.springer.com/article/10.1007/s00268-018-4762-z
https://onlinelibrary.wiley.com/doi/abs/10.1007%2Fs00268-018-4762-z
https://www.ncbi.nlm.nih.gov/pubmed/30105638
https://www.proquest.com/docview/2087789542
https://search.proquest.com/docview/2088292322
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED_RIk17GftgrIxNnsTTJqPEceJ0b4V-ZAi2aS0ab5FdO9K0KkUpFRJ_PXf5YmiIiT1FSRz7ZJ_vfvHPvgPYV9HcamM97gJjuNRScSMN3qJhVCYKjYnovHMyVV_P4-GIwuSIduki_33QMJKloW7PutHfAu27osWgSPDrDmyi6wllFzYHo-PkpOUOVOTVDKXkiF6Chsu8r5K73ugviPkHPXoXvJbeZ7z1P3I_h2c11mSDSjlewIbLX8KT05pNfwUFGgfKKYr4m030YmEWZIYKdkSaUHxmyfKK_XCr8rgWG1ZMDhtUG0DYt_UlCuDYr5zNrpasDFhbYLnk-yGjJWOElYzOrrAySR-rmaFtOBuPZkcJr3Mw8LlE784j4wkXeLavnTPo7P3Amdhk1vOcDXx8EluFKMT6_VDNlWetH2aZzfCDyAqrTPAauvkyd2-AzX1Kd6VlGFghtcqwFplZGzqlEfYY3YOPzVikF1WojbQNqlz2Yoq9mFIvptc92GtGK61n3SoVFN0w7odS9OBD-xrnC5EgOnfLdVkmFohqBZbZqUa5bS2gdKFokHrwqRnL28ofEEWUmvFvodOfx9PDMSI0KXcf1cRbeIpAjTa2cT_cg-5lsXbvoLOy6_e19tP1y2wyvgGbW_4n
link.rule.ids 315,782,786,27934,27935,41074,42143,48345,48348,48358,49650,49653,49663,52154
linkProvider Springer Nature
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT9wwEB7BIrW8AD1ZjtaV-tTKUmI7cZa35VhCC7QqW5U3y147EtIqi7KskPj1jJ2jRa2K2sckjjPy2OMv_uYAeC_TidXGRtRxY6jQQlIjDF6iYZQmTYxJfbxzfiHPL7PDI58mh7exMMHbvaUkg6Xugt3874J3vPKnQSmjd8uw4pOdRz1YGZ6Mj0cdeSDTqKEoBUX4wlsy80-dPNyOfsOYv_CjD9Fr2H5G6_8l-AasNWiTDOvp8QyWXPkcnpw1fPoLqNA8-KqiiMDJsZ5OzdQboooc-LlQ7ZF8dku-uXkI2CKHNZdDhrULCPmyuEEBHLkqyfh2RkLK2grb5V_3iT80RmBJfPQKCWX6SMMNvYTvo6PxQU6bKgx0InB_p6mJmOORHWjnDG73MXcmM4WNImd5jHcyKxGH2HiQyImMrI2TorAFvpBaZqXhr6BXzkq3CWQS-4JXWiTcMqFlgb2IwtrESY3Ax-g-fGiVoa7rZBuqS6scRlHhKCo_iuquDzutulSz7uaK-fyG2SARrA_vuse4YjwNoks3W4Q2GUNcy7DN61rN3de4LxiKJqkPH1td_uz8L6KwMDUeF1r9-HSxP0KMJsTWP33iLTzNx2en6vTk_PM2rCJs825uNE52oHdTLdwuLM_t4k2zFO4BxQsAjw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD5inTTxMti4lY1hJJ5A1hLHiVNeULe2hDHGxIbgzbJrR5pUpVPaatJ-_c7JbUwgEOIxiWM7PvbxF3_nAvBaJVNnrAu4j6zl0kjFrbR4iYpR2SS2NiF_5-xMnfxIR2MKk_O-9YWprN1bSrL2aaAoTcVy_9Ll-53jG_06kBEWnQwlgl-vwbok08IerA_HR9lxRySoJGjoSskRykQtsfm7Su5uTb_gzZ-40rtIttqKJg_--yMewmaDQtmwnjZbcM8X27DxueHZH0GJaoOyjSIyZx_MbGZnpKBKdkhzpHzHsvkV--oXlSMXG9UcDxvWpiHsy2qJnfHsomDnV3NWhbItsVx2esDoMBkBJyOvFlal72MNZ_QYvk3G54cZb7Iz8KnEfZ8nNhA-CtzAeG8RBoSRt6nNXRB4F4V4J3UKJeLCQaymKnAujPPc5fhC4oRTNnoCvWJe-GfApiElwjIyjpyQRuVYi8ydi70yCIis6cObVjD6sg7Cobtwy9UoahxFTaOor_uw24pON-txoQXFPUwHsRR9eNU9xpVE9Igp_HxVlUkF4l2BZZ7WIu9aiyiRKKqqPrxt5Xpb-R-6Iqpp8vdO6-9HZwcTxG5SPv-nJl7Cxulooo8_nnzagfuI5sj6jYfxLvSW5cq_gLWFW-01q-IGfmgJWw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidental+Gallbladder+Cancer%3A+How+Residual+Disease+Affects+Outcome+in+Two+Referral+HPB+Centers+from+South+America&rft.jtitle=World+journal+of+surgery&rft.au=Gil%2C+Luis&rft.au=Aretxabala%2C+Xabier&rft.au=Lendoire%2C+Javier&rft.au=Duek%2C+Fernando&rft.date=2019-01-15&rft.pub=Springer+International+Publishing&rft.issn=0364-2313&rft.eissn=1432-2323&rft.volume=43&rft.issue=1&rft.spage=214&rft.epage=220&rft_id=info:doi/10.1007%2Fs00268-018-4762-z&rft.externalDBID=10.1007%252Fs00268-018-4762-z&rft.externalDocID=WJSBF09144
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-2313&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-2313&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-2313&client=summon